A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Ivabradine Initiated at the Time of Discharge From the Observation Unit
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Ivabradine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms OBSERVE-IVA
- 02 Oct 2018 Planned End Date changed from 1 Jul 2019 to 30 Jun 2020.
- 02 Oct 2018 Planned primary completion date changed from 1 Jun 2019 to 31 Dec 2019.
- 02 Oct 2018 Status changed from not yet recruiting to recruiting.